UCSD Altman Clinical and Translational Research Institute (Site 1013) is a clinical research site located in La Jolla, California, United States 92037-0943.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
UCSD Altman Clinical and Translational Research Institute (Site 1013) has participated in 1 clinical trials.
Therapeutic areas: Systemic Sclerosis With and Without Interstitial Lung Disease.
Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCSD Altman Clinical and Translational Research Institute (Site 1013) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCSD Altman Clinical and Translational Research Institute (Site 1013) has 1 clinical trials on record. Their work covers Systemic Sclerosis With and Without Interstitial Lung Disease.
UCSD Altman Clinical and Translational Research Institute (Site 1013) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.